Back to search

Article

The Platform Technology Approach to mRNA Product Development and Regulation

2024-04-16

Abstract excerpt

mRNA-lipid nanoparticle (LNP) medicinal products can be considered a platform technology because the development process is similar for different diseases and conditions, with similar noncoding mRNA sequences and lipid nanoparticles and essentially unchanged manufacturing and analytical methods utilised often for different products. It is critical not to lose the momentum built using the platform approach during t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06952b43-da99-5f38-a75b-84346896aa5c
DOI
10.20944/preprints202404.1060.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Platform Technology Approach to mRNA Product Development and RegulationDOI 10.20944/preprints202404.1060.v1
mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity
Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsSemantic proximity
mRNA Vaccines Five Years After COVID-19: Lessons in Platform Design, Real-World Effectiveness, and EquitySemantic proximity
From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity
Advancing mRNA vaccines for infectious diseases: key components, innovations, and clinical progressSemantic proximity
Delivering the Message: Translating mRNA Therapy for Liver Inherited Metabolic DiseasesSemantic proximity
mRNA therapeutics: beyond vaccine applicationsSemantic proximity
Future considerations for the mRNA-lipid nanoparticle vaccine platformSemantic proximity
mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity
Engineering of mRNA vaccine platform with reduced lipids and enhanced efficacySemantic proximity
From structural design to delivery: mRNA therapeutics for cancer immunotherapySemantic proximity
Select a neighboring publication to make it the new centre.